Daily Brief Australia: RPMGlobal Holdings Limited, BHP Group Ltd, Forrestania Resources Ltd, Beetaloo Energy Australia, Fisher & Paykel Healthcare Cor and more

• RPMGlobal Holdings Limited (RUL AU) entered a scheme implementation deed with Caterpillar Inc (CAT US) at A$5.00 per share, a 32.6% premium to the undisturbed price.
• The key scheme conditions are RPM shareholder, FIRB and ACCC approval. RPM’s benign shareholder structure facilitates completion.
• The offer is attractive. At the last close and for an 18 February 2026 payment, the gross/annualised spread is 2.7%/7.8%.  

• BHP shares retesting the August low, then rallying to a recent high suggests the stock is poised to move higher, Fairmont Equities’ Michael Gable reports.

• Forrestania Resources is a junior exploration company with a diversified portfolio of gold, lithium, nickel, and copper projects strategically located in the well-endowed mineral belts of Western Australia.
• The company is actively advancing its key projects through exploration drilling, resource definition, and strategic acquisitions, with a recent focus on consolidating gold assets in the Forrestania and Southern Cross regions.
• As a pre-revenue exploration company, Forrestania is reliant on capital markets to fund its activities, making its financial performance and future prospects intrinsically linked to exploration success and commodity market sentiment.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

• Beetaloo Energy Australia Limited (ASX:BTL) is a gas development company, with onshore Northern Territory (NT) gas exploration and development assets.
• BTL has the largest tenement position in the highly prospective Greater McArthur Basin, which includes the Beetaloo Sub-basin.
• The Carpentaria-5H (C-5H) is in its testing phase with IP30 data expected in October.

• Context: The Fisher & Paykel Health (FPH AU) vs. ResMed Inc (RMD AU) price-ratio has deviated more than two standard deviations from its one-year average, presenting a potential relative value opportunity.
• Highlights: Going long Fisher & Paykel Health (FPH AU) and short ResMed Inc (RMD AU) targets a 7% return. However, ResMed is more attractively valued on PEG ratio basis.
• Why Read: Essential for quantitative traders seeking mean-reversion opportunities, with detailed execution framework, risk management protocols, and historical simulation showing the statistical basis for this relative value play.